Marcia Medeiros

Dr. Marcia Medeiros

Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2017 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Open access
MLMiguel Lanaspa
Miguel Lanaspa
QBQuique Bassat
Quique Bassat
MMMarcia Medeiros
Marcia Medeiros
CMCarmen Muñoz-Almagro
Carmen Muñoz-Almagro
Introduction: The respiratory airways harbor a complex succession of ecological niches with distinct but related bacterial communities. Particular challenges of respiratory microbiome research have led to limited scientific output compared to other human microbiomes. Areas covered: In this review, we summarize the current state of knowledge of the bacterial respiratory microbiome, with a particular focus on associations between the respiratory microbiome and lower respiratory tract conditions. Expert commentary: There is growing evidence that the respiratory microbiome is associated with lower respiratory infectious diseases and related conditions. Most respiratory microbiome reports are metataxonomic cross-sectional or case-control studies with relatively small sample sizes. Large, prospective projects with metatranscriptomics or metabolomics approach are needed to unravel the effect of the respiratory microbiome on health-related conditions. Moreover, standardization in sampling, library preparation, sequencing techniques and data analysis should be encouraged.

28 December 2013 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MMMarcia Medeiros
Marcia Medeiros
WFWesley L Fotoran
Wesley L Fotoran
RMRosimeire C Dalla Martha
Rosimeire C Dalla Martha
TKTony H Katsuragawa
Tony H Katsuragawa
LSLuiz Hildebrando Pereira da Silva
Luiz Hildebrando Pereira da Silva
GWGerhard Wunderlich
Gerhard Wunderlich
Background: Antibodies have an essential role in the acquired immune response against blood stageP. falciparuminfection. Although several antigens have been identified as important antibody targets, it is still elusive which antigens have to be recognized for clinical protection. Herein, we analyzed antibodies from plasmas from symptomatic or asymptomatic individuals living in the same geographic area in the Western Amazon, measuring their recognition of multiple merozoite antigens.Methods: Specific fragments of genes encoding merozoite proteins AMA1 and members of MSP and EBL families from circulatingP. falciparumfield isolates present in asymptomatic and symptomatic patients were amplified by PCR. After cloning and expression of different versions of the antigens as recombinant GST-fusion peptides, we tested the reactivity of patients’ plasmas by ELISA and the presence of IgG subclasses in the most reactive plasmas.Results: 11 out of 24 recombinant antigens were recognized by plasmas from either symptomatic or asymptomatic infections. Antibodies to MSP9 (X2DF=1 = 9.26/p = 0.0047) and MSP5 (X2DF=1 = 8.29/p = 0.0069) were more prevalent in asymptomatic individuals whereas the opposite was observed for MSP1 block 2-MAD20 (X2DF=1 = 6.41/p = 0.0206, Fisher’s exact test). Plasmas from asymptomatic individuals reacted more intensely against MSP4 (U = 210.5,p < 0.03), MSP5 (U = 212,p < 0.004), MSP9 (U = 189.5,p < 0.002) and EBA175 (U = 197, p < 0.014, Mann-Whitney’s U test). IgG1 and IgG3 were predominant for all antigens, but some patients also presented with IgG2 and IgG4. The recognition of MSP5 (OR = 0.112, IC95% = 0.021-0.585) and MSP9 (OR = 0.125, IC95% = 0.030-0.529, cross tab analysis) predicted 8.9 and 8 times less chances, respectively, to present symptoms. Higher antibody levels against MSP5 and EBA175 were associated by odds ratios of 9.4 (IC95% = 1.29-69.25) and 5.7 (IC95% = 1.12-29.62, logistic regression), respectively, with an asymptomatic status.Conclusions: Merozoite antigens were targets of cytophilic antibodies and antibodies against MSP5, MSP9 and EBA175 were independently associated with decreased symptoms.

8 January 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
JBJulyana Buery
Julyana Buery
FAFilomena Euridice Carvalho de Alencar
Filomena Euridice Carvalho de Alencar
ADAna Maria Ribeiro de Castro Duarte
Ana Maria Ribeiro de Castro Duarte
ALAna Carolina Loss
Ana Carolina Loss
CVCreuza Rachel Vicente
Creuza Rachel Vicente
CJCrispim Cerutti Junior
Crispim Cerutti Junior
In the south and southeast regions of Brazil, cases of malaria occur outside the endemic Amazon region near the Atlantic Forest in some coastal states, where Plasmodium vivax is the recognized parasite. Characteristics of cases and vectors, especially Anopheles (Kerteszia) cruzii, raise the hypothesis of a zoonosis with simians as reservoirs. The present review aims to report on investigations of the disease over a 23-year period. Two main sources have provided epidemiological data: the behavior of Anopheles vectors and the genetic and immunological aspects of Plasmodium spp. obtained from humans, Alouatta simians, and Anopheles spp. mosquitoes. Anopheles (K.) cruzii is the most captured species in the forest canopy and is the recognized vector. The similarity between P. vivax and Plasmodium simium and that between Plasmodium malariae and Plasmodium brasilianum shared between simian and human hosts and the involvement of the same vector in the transmission to both hosts suggest interspecies transfer of the parasites. Finally, recent evidence points to the presence of Plasmodium falciparum in a silent cycle, detected only by molecular methods in asymptomatic individuals and An. (K.) cruzii. In the context of malaria elimination, it is paramount to assemble data about transmission in such non-endemic low-incidence areas.

27 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMarcia Medeiros
Marcia Medeiros
HSHenrique B. da Silva
Henrique B. da Silva
ARAramys Silva Reis
Aramys Silva Reis
RBRenato Barboza
Renato Barboza
JTJoanne Thompson
Joanne Thompson
CTCarlos E. Tadokoro
Carlos E. Tadokoro
It is postulated that accumulation of malaria-infected Red Blood Cells (iRBCs) in the liver could be a parasitic escape mechanism against full destruction by the host immune system. Therefore, we evaluated the in vivo mechanism of this accumulation and its potential immunological consequences. A massive liver accumulation of P. c. chabaudi AS-iRBCs (Pc-iRBCs) was observed by intravital microscopy along with an over expression of ICAM-1 on day 7 of the infection, as measured by qRT-PCR. Phenotypic changes were also observed in regulatory T cells (Tregs) and dendritic cells (DCs) that were isolated from infected livers, which indicate a functional role for Tregs in the regulation of the liver inflammatory immune response. In fact, the suppressive function of liver-Tregs was in vitro tested, which demonstrated the capacity of these cells to suppress naive T cell activation to the same extent as that observed for spleen-Tregs. On the other hand, it is already known that CD4+ T cells isolated from spleens of protozoan parasite-infected mice are refractory to proliferate in vivo. In our experiments, we observed a similar lack of in vitro proliferative capacity in liver CD4+ T cells that were isolated on day 7 of infection. It is also known that nitric oxide and IL-10 are partially involved in acute phase immunosuppression; we found high expression levels of IL-10 and iNOS mRNA in day 7-infected livers, which indicates a possible role for these molecules in the observed immune suppression. Taken together, these results indicate that malaria parasite accumulation within the liver could be an escape mechanism to avoid sterile immunity sponsored by a tolerogenic environment.

5 August 2014 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
AFAlessandra Sampaio Bassi Fratus
Alessandra Sampaio Bassi Fratus
FCFernanda Janku Cabral
Fernanda Janku Cabral
WFWesley Luzetti Fotoran
Wesley Luzetti Fotoran
MMMarcia Medeiros
Marcia Medeiros
BCBianca Cechetto Carlos
Bianca Cechetto Carlos
GWGerhard Wunderlich
Gerhard Wunderlich
In the Amazon Region, there is a virtual absence of severe malaria and few fatal cases of naturally occurring Plasmodium falciparum infections; this presents an intriguing and underexplored area of research. In addition to the rapid access of infected persons to effective treatment, one cause of this phenomenon might be the recognition of cytoadherent variant proteins on the infected red blood cell (IRBC) surface, including the var gene encoded P. falciparum erythrocyte membrane protein 1. In order to establish a link between cytoadherence, IRBC surface antibody recognition and the presence or absence of malaria symptoms, we phenotype-selected four Amazonian P. falciparum isolates and the laboratory strain 3D7 for their cytoadherence to CD36 and ICAM1 expressed on CHO cells. We then mapped the dominantly expressed var transcripts and tested whether antibodies from symptomatic or asymptomatic infections showed a differential recognition of the IRBC surface. As controls, the 3D7 lineages expressing severe disease-associated phenotypes were used. We showed that there was no profound difference between the frequency and intensity of antibody recognition of the IRBC-exposed P. falciparum proteins in symptomatic vs. asymptomatic infections. The 3D7 lineages, which expressed severe malaria-associated phenotypes, were strongly recognised by most, but not all plasmas, meaning that the recognition of these phenotypes is frequent in asymptomatic carriers, but is not necessarily a prerequisite to staying free of symptoms.

1 November 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
WFWesley L. Fotoran
Wesley L. Fotoran
RSRachele M. Santangelo
Rachele M. Santangelo
MMMarcia Medeiros
Marcia Medeiros
MCMarcelle Colhone
Marcelle Colhone
PCPietro Ciancaglini
Pietro Ciancaglini
GWGerhard Wunderlich
Gerhard Wunderlich